Trevi Therapeutics Statistics

Total Valuation

TRVI has a market cap or net worth of $195.81 million. The enterprise value is $124.26 million.

Market Cap	195.81M
Enterprise Value	124.26M

Important Dates

The next estimated earnings date is Thursday, August 8, 2024, after market close.

Earnings Date	Aug 8, 2024
Ex-Dividend Date	n/a

Share Statistics

TRVI has 70.44 million shares outstanding. The number of shares has increased by 0.92% in one year.

Shares Outstanding	70.44M
Shares Change (YoY)	+0.92%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	1.29%
Owned by Institutions (%)	79.05%
Float	40.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.71
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.55, with a Debt / Equity ratio of 0.02.

Current Ratio	14.55
Quick Ratio	n/a
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-207.69

Financial Efficiency

Return on equity (ROE) is -39.50% and return on invested capital (ROIC) is -51.99%.

Return on Equity (ROE)	-39.50%
Return on Assets (ROA)	-36.80%
Return on Capital (ROIC)	-51.99%
Revenue Per Employee	n/a
Profits Per Employee	-$1.34M
Employee Count	25
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-33,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +25.23% in the last 52 weeks. The beta is 1.01, so TRVI's price volatility has been similar to the market average.

Beta (5Y)	1.01
52-Week Price Change	+25.23%
50-Day Moving Average	2.70
200-Day Moving Average	2.22
Relative Strength Index (RSI)	51.69
Average Volume (20 Days)	329,749

Short Selling Information

The latest short interest is 957,572, so 1.36% of the outstanding shares have been sold short.

Short Interest	957,572
Short Previous Month	960,966
Short % of Shares Out	1.36%
Short % of Float	2.35%
Short Ratio (days to cover)	2.86

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-38.27M
Pretax Income	-33.60M
Net Income	-33.57M
EBITDA	-33.30M
EBIT	-33.44M
Earnings Per Share (EPS)	-$0.34

Full Income Statement

Balance Sheet

The company has $72.82 million in cash and $1.27 million in debt, giving a net cash position of $71.55 million or $1.02 per share.

Cash & Cash Equivalents	72.82M
Total Debt	1.27M
Net Cash	71.55M
Net Cash Per Share	$1.02
Equity (Book Value)	72.33M
Book Value Per Share	1.03
Working Capital	71.49M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$33.98 million and capital expenditures -$80,000, giving a free cash flow of -$34.06 million.

Operating Cash Flow	-33.98M
Capital Expenditures	-80,000
Free Cash Flow	-34.06M
FCF Per Share	-$0.34

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TRVI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.92%
Shareholder Yield	-0.92%
Earnings Yield	-17.14%
FCF Yield	-17.39%

Analyst Forecast

The average price target for TRVI is $8.00, which is 187.77% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.00
Price Target Difference	187.77%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-11.62%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2